BNET Industries

Market Cap:$150.0B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Stocks May Move Modestly Higher To Kick Off Christmas Week - U.S. Commentary
-
A Dividend-Stock Holiday Shopping List
-
Pfizer whistleblower wins 2009 honor for business ethics: Complaint led to largest criminal fine in...
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Adimab Signs Deal with Pfizer
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
News & Analysis
Filter by
benefits and pfizer inc. - All News and Analysis
Pfizer Blasted in Canada for $780K CME Program
Pfizer PFE can't catch a break in Canada right now. It's being blasted for a C$780,000 continuing medical education program it has set up through the Canadian Medical Association. Critics believe that doctor education should not be influenced by drug companies, which have a different set of interests than patients....
Pfizer, Inc. Q3 2009 Earnings Call Transcript
Question-and-Answer SessionOperator Operator Instructions. Our first question, David Reisinger, Morgan Stanley. David Reisinger - Morgan Stanley Thanks, very much. I guess I have two questions, the first is for Jeff and the second is for Frank and both of these are kind of high level; Jeff, can you please...
Pfizer to Cap Retiree Health Benefits: Out of Time? Out of Luck.
Pfizer is to cap the amount of healthcare benefits it will pay to retired employees based on their years of service with the company, according to The Day. Any retiree who hasn't worked long enough for Pfizer or who has expensive medical bills may find Pfizer's willingness to continue covering...
Pfizer Lab Worker Alleges Virus Was Loose in Lunchroom
A former molecular biologist at Pfizer's Groton, Conn., plant alleges that she was told to stop documenting safety concerns at the lab even though she was a member of the company's health and safety committee. by Jim Edwards
As Lilly, Pfizer Lobby Against Obama Healthcare Plan, Their Execs Enjoy Gold-Plated Coverage
Eli Lilly, Pfizer, and PhRMA all oppose a pubic heathcare plan, according to the Center for Responsive Politics. But their top executives have health insurance plans which include cash payments of thousands of dollars and coverage that extends for years if they get laid off. by Jim Edwards
Pfizer Violated Own Rules to Hide Depression Drug Studies
Pfizer is accused of "deception through concealment" and "cheating" in failing to disclose nine of 16 trials of an antidepressant, Edronax reboxetine in Germany. The German Institute for Quality and Efficiency in Health Care slammed Pfizer in a press release. by Jim Edwards
Suit: Pfizer Docs Ran the NIH's Cholesterol Education Program
In 2003, half the members of the National Institutes of Health's National Cholesterol Education Program were also members of the Pfizer-funded National Lipid Education Council, according to a failed whistleblower lawsuit. by Jim Edwards
Lilly, Pfizer and AstraZeneca Jockeying for Position on Healthcare Reform
Eli Lilly, Pfizer, Bayer, Roche and AstraZeneca all agree on healthcare reform in the U.S.: They want to see the system changed so long as it in no way hurts their companies. by Jim Edwards
Pfizer's Flip-Flop on the Trovan Settlement
Pfizer is close to settling the Trovan case for $75 million, the Washington Post reported Saturday. BNET readers learned of this development on March 6. (Back story here.) Back then, Pfizer spokesperson waved BNET off the story, saying news of a settlement was "not accurate" because talks...
Wyeth CEO Got 69% Pay Raise; Was "Required" to Use Helicopter; Plus $24 Million Pfizer Sale Bonus
Wyeth CEO Bernard Poussot received a 69 percent compensation raise in 2008, to $21.3 million, in addition to a $24 million change-in-control bonus for selling his company to Pfizer.* Wyeth also took the explanation of executive perks to new levels, saying that Wyeth "requires" Poussot to travel...
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
